Eligibility Lymphoma, Non-Hodgkin NCT01868035

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
male or female subjects age 18 to 80 years, inclusive, with any international prognostic index score; treated with 6 or more cycles of first-line chop chemotherapy and achieved a pr, cru, or cr
Description

gender, age, chemotherapy

Data type

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
UMLS CUI [3]
C0392920
UMLS CUI [4]
C1704632
de novo diffuse large b-cell nhl according to the real classification; ann arbor stage iii, stage iv, or bulky stage ii disease (any mass ≥10 cm in diameter)
Description

diffuse large b-cell nhl

Data type

boolean

Alias
UMLS CUI [1]
C0079744
less than an average of 25% of the intratrabecular marrow space involved by nhl in bilateral bone marrow biopsy specimens or <10% involvement with nhl from unilateral bone marrow biopsy; tumor tissue expressing the cd20 antigen
Description

bone marrow biopsy, cd20

Data type

boolean

Alias
UMLS CUI [1]
C0005954
UMLS CUI [2]
C0054946
≥60% performance status on the karnofsky performance scale and an anticipated survival of at least 3 months
Description

karnofsky, life expectancy

Data type

boolean

Alias
UMLS CUI [1]
C0206065
UMLS CUI [2]
C0023671
absolute neutrophil count (anc) ≥1500 cells/mm3 and platelet count ≥100,000/mm3
Description

anc, platelet count

Data type

boolean

Alias
UMLS CUI [1]
C0948762
UMLS CUI [2]
C0032181
adequate renal function (serum creatinine <1.5 × upper limit of normal [uln]) and hepatic function (total bilirubin ≤2.0 × uln and aspartate aminotransferase <5 × uln)
Description

creatinine, bilirubin, ast

Data type

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2]
C1278039
UMLS CUI [3]
C0201899
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior radiation, prior biological therapy, or prior chemotherapy other than first-line chop
Description

therapy

Data type

boolean

Alias
UMLS CUI [1]
C0087111
active bilateral obstructive hydronephrosis
Description

hydronephrosis

Data type

boolean

Alias
UMLS CUI [1]
C0521622
new york heart association class iii or iv heart disease or other serious illness
Description

nyha

Data type

boolean

Alias
UMLS CUI [1]
C1275491
prior malignancy other than lymphoma (except for adequately treated skin cancer, in situ cervical cancer, or other cancer for which they had been disease-free for >5 years)
Description

malignancy

Data type

boolean

Alias
UMLS CUI [1]
C0006826
human immunodeficiency virus infection
Description

hiv

Data type

boolean

Alias
UMLS CUI [1]
C0019682
hama positive
Description

hama

Data type

boolean

Alias
UMLS CUI [1]
C1291910
brain or leptomeningeal metastases at any time since diagnosis
Description

cns metastases

Data type

boolean

Alias
UMLS CUI [1]
C0686377
active infection requiring intravenous anti-infectives
Description

infection

Data type

boolean

Alias
UMLS CUI [1]
C0009450
pregnant or breastfeeding
Description

pregnancy, lactation

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147

Similar models

Eligibility Lymphoma, Non-Hodgkin NCT01868035

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
gender, age, chemotherapy
Item
male or female subjects age 18 to 80 years, inclusive, with any international prognostic index score; treated with 6 or more cycles of first-line chop chemotherapy and achieved a pr, cru, or cr
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0392920 (UMLS CUI [3])
C1704632 (UMLS CUI [4])
diffuse large b-cell nhl
Item
de novo diffuse large b-cell nhl according to the real classification; ann arbor stage iii, stage iv, or bulky stage ii disease (any mass ≥10 cm in diameter)
boolean
C0079744 (UMLS CUI [1])
bone marrow biopsy, cd20
Item
less than an average of 25% of the intratrabecular marrow space involved by nhl in bilateral bone marrow biopsy specimens or <10% involvement with nhl from unilateral bone marrow biopsy; tumor tissue expressing the cd20 antigen
boolean
C0005954 (UMLS CUI [1])
C0054946 (UMLS CUI [2])
karnofsky, life expectancy
Item
≥60% performance status on the karnofsky performance scale and an anticipated survival of at least 3 months
boolean
C0206065 (UMLS CUI [1])
C0023671 (UMLS CUI [2])
anc, platelet count
Item
absolute neutrophil count (anc) ≥1500 cells/mm3 and platelet count ≥100,000/mm3
boolean
C0948762 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
creatinine, bilirubin, ast
Item
adequate renal function (serum creatinine <1.5 × upper limit of normal [uln]) and hepatic function (total bilirubin ≤2.0 × uln and aspartate aminotransferase <5 × uln)
boolean
C0201976 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
C0201899 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
therapy
Item
prior radiation, prior biological therapy, or prior chemotherapy other than first-line chop
boolean
C0087111 (UMLS CUI [1])
hydronephrosis
Item
active bilateral obstructive hydronephrosis
boolean
C0521622 (UMLS CUI [1])
nyha
Item
new york heart association class iii or iv heart disease or other serious illness
boolean
C1275491 (UMLS CUI [1])
malignancy
Item
prior malignancy other than lymphoma (except for adequately treated skin cancer, in situ cervical cancer, or other cancer for which they had been disease-free for >5 years)
boolean
C0006826 (UMLS CUI [1])
hiv
Item
human immunodeficiency virus infection
boolean
C0019682 (UMLS CUI [1])
hama
Item
hama positive
boolean
C1291910 (UMLS CUI [1])
cns metastases
Item
brain or leptomeningeal metastases at any time since diagnosis
boolean
C0686377 (UMLS CUI [1])
infection
Item
active infection requiring intravenous anti-infectives
boolean
C0009450 (UMLS CUI [1])
pregnancy, lactation
Item
pregnant or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])